Durysta, an exciting new glaucoma treatment

Nahndi Bush, M.D. • March 29, 2021

Durysta, an exciting new glaucoma treatment

Anyone who needs to take eye drops on a daily basis for conditions like glaucoma knows that at times it can be challenging. We forget to take them, lose the bottle, or sometimes run out before insurance will allow them to be refilled. Sometimes putting the drops in the eye is difficult, and we worry whether we or a family member are getting enough medication into the eye.

Recent developments in the pharmaceutical world have led to alternative ways of taking medications. Glaucoma, an optic nerve disorder that requires the lowering of fluid pressure within the eye to prevent damage to vision, is one condition benefiting from this revolution. A glaucoma medication previously available only in drop form (Bimatoprost) is now available in a tiny, dissolvable implant that can be placed into the front chamber of the eye during an office visit. This microscopic pellet, the Durysta implant (Bimataprost 10mcg , by Allergan) then gradually and consistently releases the medication within the eye, reducing the need to place daily drops. The procedure is painless, takes less than a minute, and can provide benefits for months or more.

It is likely that more implantable medications for glaucoma are on the horizon. Some are already in use to treat inflammatory and diabetic eye conditions. These treatments may become the new face of vision therapy in the future, and change life for many patients. Ask your eye doctor if you may be a candidate for Durysta or similar treatments to manage your eye conditions.

< Older Post Newer Post >

NJ Eye and Ear Specialists Begin Performing Procedures at New State-of-the-Art Precision Surgery Center

June 15, 2026

NJ Eye and Ear Specialists Begin Performing Procedures at New State-of-the-Art Preision Surgery Center

Why Your Runny or Stuffy Nose Might Not Be “Just Allergies”

March 30, 2026

Nose always runny?

January is Glaucoma Awareness Month: Protect Your Vision with Early Detection in New Jersey

January 20, 2026

January is Glaucoma Awareness Month, a time to raise awareness about one of the leading causes of irreversible vision loss in the United States. Often called the “silent thief of sight,” glaucoma can develop without noticeable symptoms in its early stages, making regular eye exams in New Jersey essential for protecting long-term vision health. More than four million Americans are currently living with glaucoma, and many do not realize they have it. The condition damages the optic nerve, typically due to increased eye pressure, and often begins by affecting peripheral vision. Without early detection and treatment, this vision loss can become permanent. Who Is at Risk for Glaucoma? While anyone can develop glaucoma, certain factors can increase your risk, including: Being over the age of 60 Having a family history of glaucoma Belonging to certain ethnic backgrounds Living with diabetes or high eye pressure Understanding your personal risk and scheduling routine glaucoma screenings in New Jersey can make a meaningful difference in preserving your sight. The Importance of Comprehensive Eye Exams The most effective way to detect glaucoma early is through a comprehensive dilated eye exam. This exam allows your eye care provider to measure eye pressure, evaluate the optic nerve, and check for subtle changes in your field of vision—often before symptoms appear. Book Your Glaucoma Screening in New Jersey At NJ Eye and Ear, our ophthalmology and optometry team provides personalized care using advanced diagnostic technology to help patients detect and manage glaucoma as early as possible. This January, take a proactive step toward protecting your vision. Book your glaucoma screening in New Jersey today and safeguard your sight for the future.